Insights

How Leap Reduces the Total Cost of Multiple Sclerosis Care

Image

For patients requiring long-term MS infusions like Ocrevus or Tysabri, traditional hospital-based treatment comes at a significant financial and logistical cost. Leap provides an alternative: cost-effective, patient-friendly infusion therapy that eliminates unnecessary expenses and administrative barriers.

Key Areas Where Leap Health Saves Employers Money

Leap Health's model addresses the biggest cost drivers in MS treatment by:

  • Eliminating unnecessary drug markups: On average, Leap saves $51,000 annually per patient.Leap Health’s pass-through pricing ensures employers pay the actual cost of MS drugs, with no additional markups.
  • Reducing site-of-service costs: Leap shifts patients away from high-cost hospital outpatient infusions, which can inflate treatment costs by up to 500%.With home infusion, patients avoid facility fees and excessive administrative costs.
  • Improving adherence and reducing long-term disability: Missed or delayed infusions lead to worsening symptoms, hospitalizations and long-term disability claims.Leap Health’s proactive care coordination ensures MS patients stay on schedule, reducing complications and improving health outcomes.
  • Enhancing workforce productivity: The average MS patient spends an entire day off work for an infusion due to travel, long wait times and post-treatment recovery.Leap Health cuts infusion time to just two hours at home, allowing patients to return to work and daily activities sooner.

March Is National MS Education and Awareness Month

March is a time to raise awareness about MS and advocate for better, more affordable care. For employers, this means recognizing the significant financial and workforce burden that MS places on their organizations and taking action to reduce these costs without sacrificing care quality.

Leap is committed to making MS treatment more accessible, cost-effective, and patient-friendly. By eliminating inflated infusion costs and reducing workplace disruptions, Leap helps employers provide better care while saving millions annually.

Share this post

More insights

Image
Education

The Infusion Cost Crisis: Why Medical Benefit Drug Spend Keeps Escalating

For employers, however, infusion care has quietly become one of the fastest-growing and least unders...

Read article
Image
News

Leap Joins the Castlight Ecosystem to Simplify Infusion Care

Leap has joined the Castlight ecosystem to give TPAs and employers a more transparent, predictable, ...

Read article
Image
Insights

Rebates, what rebates? Understanding pharmacy rebates for J-Code drugs

Pharmacy rebates are manufacturer-paid discounts, typically negotiated behind

Read article
Image
Education

Demystifying Specialty Drug Pricing Acronyms, and Why They All Fail Employers

Behind the exorbitant costs of infusion therapies, you’ll find layers of complexity—and three acrony...

Read article
Image
Clinical

Safely Infusing Immunoglobulin in the Home Setting: Clinical Considerations and Best Practices

Immunoglobulin (Ig) therapies are essential in the treatment of primary immunodeficiency (PID), chro...

Read article
Image
News

Leap and Amwins Partner to Deliver Low-Cost, Convenient Infusion Therapy

Leap and Amwins Rx, today announced a strategic collaboration that will bring significant benefits t...

Read article
Image
Case Study

Bringing Relief Home for Annie

Helping a working parent stay on track with infusion care

Read article
Image
News

Leap and Blackhawk Claims Service Partner to Reduce Specialty Medication Costs and Improve Patient Access

We're so excited to announce our strategic partnership with Blackhawk Claims Service, a leading thir...

Read article
Image
Insights

The High Cost of RA Infusions – and How Leap Fixes It

For many patients, biologic infusions such as Remicade, Actemra, and Orencia are essential but they ...

Read article
Image
Insights

Why Home Infusion Is Safe, Effective – and Preferred by Patients

More patients and employers are choosing home infusion as a safe, effective alternative to hospital-...

Read article